MoneyWorks4Me

Kilitch Drugs(India) - Quaterly Results

27 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 391.36 millions as compared to Rs. 432.83 millions during the year-ago period.A slender decline of -28.99% was recorded to Rs. 36.42  millions from Rs. 51.29 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 61.13 millions from 81.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 391.36 432.83 -9.58 1315.99 1177.84 11.73 1315.99 1177.84 11.73
Other Income 8.96 14.32 -37.43 61.89 45.98 34.60 61.89 45.98 34.60
PBIDT 61.13 81.19 -24.71 265.06 217.71 21.75 265.06 217.71 21.75
Interest 4.45 4.07 9.34 19.08 9.85 93.71 19.08 9.85 93.71
PBDT 56.68 77.12 -26.50 245.98 207.86 18.34 245.98 207.86 18.34
Depreciation 4.10 3.73 9.92 12.44 13.37 -6.96 12.44 13.37 -6.96
PBT 52.58 73.39 -28.36 233.54 194.49 20.08 233.54 194.49 20.08
TAX 16.16 22.10 -26.88 57.79 37.32 54.85 57.79 37.32 54.85
Deferred Tax 3.01 1.70 77.06 -5.86 -4.66 25.75 -5.86 -4.66 25.75
PAT 36.42 51.29 -28.99 175.75 157.17 11.82 175.75 157.17 11.82
Equity 160.82 155.82 3.21 160.82 155.82 3.21 160.82 155.82 3.21
PBIDTM(%) 15.62 18.76 -16.73 20.14 18.48 8.97 20.14 18.48 8.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..